pre-ipo
Stage
About
Intellia Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing CRISPR/Cas9-based genome editing therapies to treat genetic diseases.
Explore Intellia Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.